FGF-2, TGFβ-1, PDGF-A and respective receptors expression in pleomorphic adenoma myoepithelial cells: An in vivo and in vitro study

Journal of Applied Oral Science

Volumn 18, Issue 1, 2010, Pages 83-91

  Miguita, Lucyene ^a   Martinez, Elizabeth Ferreira ^a   de Araújo, Ney Soares ^a   de Araújo, Vera Cavalcanti ^a  

^a SÃO LEOPOLDO MANDIC INSTITUTE AND RESEARCH CENTER   (Brazil)

Author keywords

FGF 2; Growth factors; Myoepithelial cells; PDGF A; Pleomorphic adenoma; TGF 1

Indexed keywords

ACTIN; ACTIN BINDING PROTEIN; CALCIUM BINDING PROTEIN; CALPONIN; CYTOKERATIN 7; FGFR1 PROTEIN, HUMAN; FGFR2 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; MUSCLE PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET-DERIVED GROWTH FACTOR A; PROTEIN SERINE THREONINE KINASE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA TYPE II RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR-BETA TYPE II RECEPTOR; VIMENTIN;

ADULT; ARTICLE; CELL CULTURE; CELL NUCLEUS; COMPARATIVE STUDY; CYTOPLASM; EPITHELIUM CELL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOHISTOCHEMISTRY; JAW TUMOR; LIP TUMOR; MALE; MUSCLE CELL; PATHOLOGY; PLEOMORPHIC ADENOMA; SALIVARY GLAND TUMOR; SMOOTH MUSCLE; ULTRASTRUCTURE;

ACTINS; ADENOMA, PLEOMORPHIC; ADULT; CALCIUM-BINDING PROTEINS; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; EPITHELIAL CELLS; FEMALE; FIBROBLAST GROWTH FACTOR 2; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; LIP NEOPLASMS; MALE; MICROFILAMENT PROTEINS; MUSCLE CELLS; MUSCLE PROTEINS; MUSCLE, SMOOTH; PALATAL NEOPLASMS; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SALIVARY GLAND NEOPLASMS; TRANSFORMING GROWTH FACTOR BETA1; VIMENTIN; YOUNG ADULT;

EID: 77950879221     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/S1678-77572010000100014     Document Type: Article

References (49)

1. Alvarez RH, Kantarjian HM, Cortes JE. Biology of platelet-derived growth factor and its involvement in disease. Mayo Clin Proc. 2006;81(9):1241-57.
2. Araújo VC, Altemani A, Furuse C, Martins MT, Araújo NS. Immunoprofile of reactive salivary myoepithelial cells in areas of in situ carcinoma ex-pleomorphic adenoma. Oral Oncol. 2006;42:1011-6.
3. Baldin V, Roman A, Bosc-Bierne I, Amalric F, Bouche G. Translocation of bFGF to the nucleus is G1 phase cell cycle specific in bovine aortic endothelial cells. EMBO J. 1990;9(5):1511-7.
4. Barsky SH, Alpaugh ML. Myoepithelium: methods of culture and study. In: Pfragner R, Freshney RI, editors. Culture of human tumor cells. New Jersey: John Wiley & Sons; 2004. p. 221-60.
5. Barsky SH, Karlin NJ. Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia. 2005;10(3):249-60.
6. Barsky SH. Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp Mol Pathol. 2003;74(2):113-22.
7. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature. 2004;432:332-7.
8. Bryant DM, Stow JL. Traffic interchange nuclear translocation of cell-surface receptors: lessons from fibroblast growth factor. Traffic. 2005;6(10):947-53.
9. Chaffer CL, Dopheide B, Savagner P, Thompson EW, Williams ED. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. Differentiation. 2007;75:831-42.
10. Chen Y, Li X, Eswarakumar VP, Seger R, Lonai P. Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PTB is require for embryoid body differentiation. Oncogene. 2000;19:3750-6.
11. Delrieu I. The high molecular weight isoforms of basic fibroblast growth factor (FGF-2): an insight into an intracrine mechanism. FEBS Lett. 2000;468:6-10.
12. Demasi APD, Furuse C, Soares AB, Altemani A, Araújo VC. Peroxiredoxin 1, platelet-derived growth factor A, and platelet-derived growth factor receptor á are overexpressed in carcinoma ex pleomorphic adenoma: association with malignant transformation. Hum Pathol. 2009;40(3):390-7.
13. Dow JK, deVere White RW. Fibroblast growth factor 2: its structure and property, paracrine function, tumor angiogenesis, and prostate-related mitogenic and oncogenic functions. Urology. 2000;55:800-6.
14. Gabrilove JL. Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies. Oncologist. 2001;6(5):4-7.
15. Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. 2005;16:179-86.
16. Heldin C, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev. 1999;79(4):1283-316.
17. Itoh N, Ornitiz DM. Evolution of the FGF and FGFR gene families. Trends Genet. 2004;20(11):563-9.
18. Jans DA, Hassan G. Nuclear targeting by growth factors, cytokines, and their receptors: a role in signaling? Bioessays. 1998;20(5):400-11.
19. Ke Y, Fernig DG, Wilkinson MC, Winstanley JHR, Smith JA, Rudland PS, et al. The expression of basic fibroblast growth factor and its receptor in cell lines from normal human mammary gland and a benign mammary lesion. J Cell Sci. 1993;106:135-43.
20. Kusafuka K, Yamaguchi A, Kayano T, Takemura T. Immunohistochemical localization of members of the transforming growth factor (TGF)-â superfamily in normal human salivary glands and pleomorphic adenomas. J Oral Pathol Med. 2001;30(7):413-20.
21. Kusafuka K, Yamaguchi A, Kayano T, Takemura T. Immunohistochemical localization of fibroblast growth factors (FGFs) and FGF receptor-1 in human normal salivary glands and pleomorphic adenomas. J Oral Pathol Med. 1998;27(7):287-92.
22. Liang J, Chen P, Hu Z, Zhou X, Chen L, Wang Y, et al. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis. 2008;29(12):2341-6.
23. Liu J, Horner T, Rogers RA, Schinitzer JE. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem. 1997;272(11):7211-22.
24. Meyer KB, Maia A, O'Reilly M, Teschendorff AE, Chin S, Caldas C, et al. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol. 2008;6(5):1098-103.
25. Moffa AB, Tannheimer SL, Ethier SP. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells. Mol Cancer Res. 2004;2(11):643-52.
26. Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, et al. Immunohistochemical localization of fibroblast growth factor-1 (FGF-1), FGF-2 and fibroblast growth factor receptor-1 (FGFR-1) in pleomorphic adenoma of the salivary glands. J Oral Pathol Med. 1997;26:17-22.
27. Myoken Y, Myoken Y, Okamoto T, Sato JD, Kan M, McKeehan WL, et al. Immunohistochemical localization of fibroblast growth factor-1 (FGF-1), FGF-2 and fibroblast growth factor receptor-1 (FGFR-1) in human malignant salivary gland tumors. J Oral Pathol. 1996;178:429-36.
28. Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, et al. FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun. 2000;277:643-9.
29. Ornitz DM, Itoh N. Fibroblast growth factors protein family review. Genome Biol. 2001;2(3):REVIEWS3005.
30. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta. 2006;1775(1):21-62.
31. Patel VN, Rebustini IT, Hoffman MP. Salivary gland branching morphogenesis. Differentiation. 2006;74:349-64.
32. Pietras K, Pahler J, Bergers G, Hanahan D. Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 2008;5(1):e19.
33. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 2005;16(2):159-78.
34. Ranganathan P, Agrawal A, Bhushan R, Chavalmane AK, Kalathur RKR, Takahashi T, et al. Expression profiling of genes by TGFb: Differencial regulation in normal and tumor cells. BMC Genomics. 2007;8:98.
35. Reilly JF, Maher PA. Impotinâ-mediated nuclear import of fibroblast growth factor receptor: Role in cell proliferation. J Cell Biol. 2001;152(6):1307-12.
36. Roberts AB. Molecular and cell biology of TGF-beta. Miner Electrolyte Metab. 1998;24(2-3):111-9.
37. Rudland PS, Fernig DG, Smith JA. Growth factors and their receptors in neoplastic mammary glands. Biomed Pharmacother 1995;49:389-99.
38. Schmahl J, Raymond CS, Soriano P. PDGF signaling specificity is a mediated through multiple immediate early genes. Nat Gen. 2007;39(1):52-60.
39. Shah AH, Tabayoyong WB, Kimm SY, Kim SJ, Van Parijs L, Lee C. Reconstitution of lethally irradiated adult mice with dominant negative TGF-beta type II receptor-transduced bone marrow leads to myeloid expansion and inflammatory disease. J Immunol. 2002;169(7):3485-91.
40. Siegel PM, Shu W, Cardiff RD, Muller WJ, Massague J: Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A. 2003;100(14):8430-5.
41. Stachowiak MK, Maher PA, Stachowiak EK. Integrative nuclear signaling in cell development. a role for FGF receptor-1. DNA Cell Biol. 2007;26(12):811-26.
42. Sternlicht MD, Barsky SH. The myoepithelial defense: a host defense against cancer. Med Hypotheses. 1997;48(1):37-46.
43. Sumitomo S, Okamoto Y, Mizutani G, Kudeken W, Mori M, Takai Y. Immunohistochemical study of fibroblast growth factor-2 (FGF-2) and fibroblast growth factor receptor (FGF-R) in experimental squamous cell carcinoma of rat submandibular gland. Oral Oncol. 1999;35(1):98-104.
44. Sverdlov M, Shajahan AN, Minshal RD. Tyrosine phosphorylation-dependence of caveolae-mediated endocytosis. J Cell Mol Med. 2007;11(6):1239-50.
45. Taverna S, Rigogliuso S, Salamone M, Vittorelli ML. Intracellular trafficking of endogenous fibroblast growth factor-2. FEBS J. 2008;275:1579-92.
46. Yeoh JSG, Haan G. Fibroblast growth factors as regulators of stem cell self-renewal and aging. Mech Ageing Dev. 2007;128:17-24.
47. Yu Z, Biro S, Fu Y, Sanchez J, Smale G, Sasse J, et al. Localization of basic fibroblast growth factor in bovine endothelial cells: immunohistochemical and biochemical studies. Exp Cell Res. 1993;204:247-59.
48. Yura Y, Yoshioka Y, Yamamoto S, Kusaka J, Bando T, Yoshida H, et al. Enhancing effects of fibroblast growth factor on the proliferation of salivary gland carcinoma cells and salivary gland carcinogenesis. J Oral Pathol Med. 2001;30(3):159-67.
49. Zwaagstra JC, Guimond A, O'Connor-McCourt MD. Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest. Exp Cell Res. 2000;258(1):121-34.